Literature DB >> 27672196

Structural Determinants for Antitoxin Identity and Insulation of Cross Talk between Homologous Toxin-Antitoxin Systems.

Lauren R Walling1, J Scott Butler2,3,4.   

Abstract

Toxin-antitoxin (TA) systems are ubiquitous in bacteria and archaea, where they play a pivotal role in the establishment and maintenance of dormancy. Under normal growth conditions, the antitoxin neutralizes the toxin. However, under conditions of stress, such as nutrient starvation or antibiotic treatment, cellular proteases degrade the antitoxin, and the toxin functions to arrest bacterial growth. We characterized the specificity determinants of the interactions between VapB antitoxins and VapC toxins from nontypeable Haemophilus influenzae (NTHi) in an effort to gain a better understanding of how antitoxins control toxin activity and bacterial persistence. We studied truncated and full-length antitoxins with single amino acid mutations in the toxin-binding domain. Coexpressing the toxin and antitoxin in Escherichia coli and measuring bacterial growth by dilution plating assayed the ability of the mutant antitoxins to neutralize the toxin. Our results identified two single amino acid residues (W48 and F52) in the C-terminal region of the VapB2 antitoxin necessary for its ability to neutralize its cognate VapC2 toxin. Additionally, we attempted to alter the specificity of VapB1 by making a mutation that would allow it to neutralize its noncognate toxin. A mutation in VapB1 to contain the tryptophan residue identified herein as important in the VapB2-VapC2 interaction resulted in a VapB1 mutant (the T47W mutant) that binds to and neutralizes both its cognate VapC1 and noncognate VapC2 toxins. This represents the first example of a single mutation causing relaxed specificity in a type II antitoxin. IMPORTANCE: Toxin-antitoxin systems are of particular concern in pathogenic organisms, such as nontypeable Haemophilus influenzae, as they can elicit dormancy and persistence, leading to chronic infections and failure of antibiotic treatment. Despite the importance of the TA interaction, the specificity determinants for VapB-VapC complex formation remain uncharacterized. Thus, our understanding of how antitoxins control toxin-induced dormancy and bacterial persistence requires thorough investigation of antitoxin specificity for its cognate toxin. This study characterizes the crucial residues of the VapB2 antitoxin from NTHi necessary for its interaction with VapC2 and provides the first example of a single amino acid change altering the toxin specificity of an antitoxin.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27672196      PMCID: PMC5116932          DOI: 10.1128/JB.00529-16

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  50 in total

Review 1.  Toxins-antitoxins: plasmid maintenance, programmed cell death, and cell cycle arrest.

Authors:  Finbarr Hayes
Journal:  Science       Date:  2003-09-12       Impact factor: 47.728

2.  (p)ppGpp controls bacterial persistence by stochastic induction of toxin-antitoxin activity.

Authors:  Etienne Maisonneuve; Manuela Castro-Camargo; Kenn Gerdes
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

Review 3.  Prokaryotic toxin-antitoxin systems--the role in bacterial physiology and application in molecular biology.

Authors:  Michal Bukowski; Anna Rojowska; Benedykt Wladyka
Journal:  Acta Biochim Pol       Date:  2011-03-11       Impact factor: 2.149

4.  The intrinsically disordered domain of the antitoxin Phd chaperones the toxin Doc against irreversible inactivation and misfolding.

Authors:  Steven De Gieter; Albert Konijnenberg; Ariel Talavera; Annika Butterer; Sarah Haesaerts; Henri De Greve; Frank Sobott; Remy Loris; Abel Garcia-Pino
Journal:  J Biol Chem       Date:  2014-10-16       Impact factor: 5.157

5.  RNase/anti-RNase activities of the bacterial parD toxin-antitoxin system.

Authors:  Ana J Muñoz-Gómez; Marc Lemonnier; Sandra Santos-Sierra; Alfredo Berzal-Herranz; Ramón Díaz-Orejas
Journal:  J Bacteriol       Date:  2005-05       Impact factor: 3.490

Review 6.  Bacterial persistence and toxin-antitoxin loci.

Authors:  Kenn Gerdes; Etienne Maisonneuve
Journal:  Annu Rev Microbiol       Date:  2012       Impact factor: 15.500

7.  The crystal structure of the Rv0301-Rv0300 VapBC-3 toxin-antitoxin complex from M. tuberculosis reveals a Mg²⁺ ion in the active site and a putative RNA-binding site.

Authors:  Andrew B Min; Linda Miallau; Michael R Sawaya; Jeff Habel; Duilio Cascio; David Eisenberg
Journal:  Protein Sci       Date:  2012-11       Impact factor: 6.725

8.  Structure and proposed activity of a member of the VapBC family of toxin-antitoxin systems. VapBC-5 from Mycobacterium tuberculosis.

Authors:  Linda Miallau; Michael Faller; Janet Chiang; Mark Arbing; Feng Guo; Duilio Cascio; David Eisenberg
Journal:  J Biol Chem       Date:  2008-10-24       Impact factor: 5.157

9.  tRNA is a new target for cleavage by a MazF toxin.

Authors:  Jason M Schifano; Jonathan W Cruz; Irina O Vvedenskaya; Regina Edifor; Ming Ouyang; Robert N Husson; Bryce E Nickels; Nancy A Woychik
Journal:  Nucleic Acids Res       Date:  2016-01-05       Impact factor: 16.971

10.  de novo synthesis of a bacterial toxin/antitoxin system.

Authors:  Valerie W C Soo; Hsin-Yao Cheng; Brian W Kwan; Thomas K Wood
Journal:  Sci Rep       Date:  2014-05-06       Impact factor: 4.379

View more
  14 in total

Review 1.  Toxin-antitoxin systems and their medical applications: current status and future perspective.

Authors:  Akriti Srivastava; Soumya Pati; Himani Kaushik; Shailja Singh; Lalit C Garg
Journal:  Appl Microbiol Biotechnol       Date:  2021-02-13       Impact factor: 4.813

Review 2.  Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.

Authors:  Christian P Ahearn; Mary C Gallo; Timothy F Murphy
Journal:  Pathog Dis       Date:  2017-06-01       Impact factor: 3.166

3.  Homologous VapC Toxins Inhibit Translation and Cell Growth by Sequence-Specific Cleavage of tRNAfMet.

Authors:  Lauren R Walling; J Scott Butler
Journal:  J Bacteriol       Date:  2018-01-10       Impact factor: 3.490

4.  Auxiliary interfaces support the evolution of specific toxin-antitoxin pairing.

Authors:  Grzegorz J Grabe; Rachel T Giorgio; Alexander M J Hall; Rhodri M L Morgan; Laurent Dubois; Tyler A Sisley; Julian A Rycroft; Stephen A Hare; Sophie Helaine
Journal:  Nat Chem Biol       Date:  2021-09-23       Impact factor: 15.040

Review 5.  Evaluating the Potential for Cross-Interactions of Antitoxins in Type II TA Systems.

Authors:  Chih-Han Tu; Michelle Holt; Shengfeng Ruan; Christina Bourne
Journal:  Toxins (Basel)       Date:  2020-06-26       Impact factor: 4.546

6.  Structural, functional and biological insights into the role of Mycobacterium tuberculosis VapBC11 toxin-antitoxin system: targeting a tRNase to tackle mycobacterial adaptation.

Authors:  Amar Deep; Prabhakar Tiwari; Sakshi Agarwal; Soni Kaundal; Saqib Kidwai; Ramandeep Singh; Krishan G Thakur
Journal:  Nucleic Acids Res       Date:  2018-11-30       Impact factor: 16.971

7.  A novel Staphylococcus aureus cis-trans type I toxin-antitoxin module with dual effects on bacteria and host cells.

Authors:  Noëlla Germain-Amiot; Yoann Augagneur; Emilie Camberlein; Irène Nicolas; Valérie Lecureur; Astrid Rouillon; Brice Felden
Journal:  Nucleic Acids Res       Date:  2019-02-28       Impact factor: 16.971

8.  Functionality and cross-regulation of the four SprG/SprF type I toxin-antitoxin systems in Staphylococcus aureus.

Authors:  Camille Riffaud; Marie-Laure Pinel-Marie; Gaëtan Pascreau; Brice Felden
Journal:  Nucleic Acids Res       Date:  2019-02-28       Impact factor: 16.971

Review 9.  Type I Toxin-Antitoxin Systems in Clostridia.

Authors:  Olga Soutourina
Journal:  Toxins (Basel)       Date:  2019-05-06       Impact factor: 4.546

10.  Analysis of expression differences of immune genes in non-small cell lung cancer based on TCGA and ImmPort data sets and the application of a prognostic model.

Authors:  Lei Sun; Zhe Zhang; Yao Yao; Wen-Ya Li; Jia Gu
Journal:  Ann Transl Med       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.